EYENOVIA, INC. (NASDAQ: EYEN) Files An 8-K Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.

EYENOVIA, INC. Exhibit
EX-99.1 2 tv507786_ex99-1.htm EXHIBIT 99.1   Exhibit 99.1       Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study   Topline results for Phase III MicroStat program expected H1 2019   New York,…
To view the full exhibit click here